Unigen’s Nutritional Ingredients Distributed by LEHVOSS Nutrition in Europe
Tacoma, Washington-February 27, 2023: Unigen, Inc. is pleased to announce partnership with Europe based LEHVOSS Nutrition. Through this mutual collaboration, three of Unigen’s patented, clinically proven ingredients have been added to the LEHVOSS Nutrition brands portfolio to be promoted in Europe: Univestin® for fast acting joint support, Attenutin™ for respiratory health support and Anivestin® for joint discomfort and oral health in companion animals.
“We are really excited for this new partnership with LEHVOSS Nutrition to bring Unigen’s three ingredients into the European market,” said Dr. Qi Jia, President and CEO. “Unigen develops its proprietary, patented, and clinically proven ingredients through rigorous scientific research using our PhytoLogix® Technology Platform, a database of comprehensive botanical profiles on over 12,000 plants and 15,000 extracts. This is synergistic with LEHVOSS Nutrition’s brands portfolio and philosophy.”
Teresita Rudà, Head of Brands and Marketing LEHVOSS Nutrition added, “We have followed Unigen’s developments and scientific research in the USA with great interest over the last six years, and we are very pleased that they see LEHVOSS as the right partner for distribution in Europe. Both technical teams have done some great teamwork, spending almost 12 months to ensure regulatory compliancy on these ingredients. We have finally achieved the stage where these three selected brands are ready for launch in Europe, our sales team is fully engaged and key customers have already started to look into them with great excitement.”
LEHVOSS Nutrition specializes in scientifically proven, trademarked ingredients manufactured by top worldwide companies and distributed by LEHVOSS subsidiaries throughout Europe. Their brands portfolio covers Healthy Aging, Weight Management, Beauty, Immune, Joint, Cardiovascular, Cognitive, Gut Health, Sport Nutrition and more. www.lehvoss-nutrition.com.
To learn more about Unigen’s research capabilities and novel ingredient pipeline, visit unigen.net.
About Unigen, Inc.
Unigen discovers, develops, and manufactures proprietary natural-product active ingredients for dietary supplements, cosmetic and personal care products, prescription medical food and botanical drug products. The company discovers its ingredients through its high throughput screening PhytoLogix® approach applied to a proprietary well-annotated collection of botanicals and a legacy mining approach applied to botanicals having known medicinal benefits. Mechanism of action, safety and efficacy are documented with extensive preclinical in vitro and in vivo testing and by human clinical studies. Unigen protects its discoveries with issued patents and patent filings in all major territories and manufactures its products to GMP standards. Unigen commercializes its proprietary ingredients through licensing and ingredient supply alliances with commercial partners engaged in the manufacture, distribution, and marketing of end-products in each of Unigen’s target markets.